Hydrochloric Acid → Phenylmethyl (2S)-4-({2'-fluoro-5'-[({[3-(4-piperidinylmethyl)phenyl]carbonyl}amino) methyl]-3-biphenylyl}methyl)-2-methyl-1-piperazinecarboxylate
反応式
CC(OC([N:8]1[CH2:13][CH2:12][CH:11]([CH2:14][C:15]2[CH:16]=[C:17]([C:21]([NH:23][CH2:24][C:25]3[CH:26]=[CH:27][C:28]([F:55])=[C:29]([C:31]4[CH:36]=[CH:35][CH:34]=[C:33]([CH2:37][N:38]5[CH2:43][CH2:42][N:41]([C:44]([O:46][CH2:47][C:48]6[CH:53]=[CH:52][CH:51]=[CH:50][CH:49]=6)=[O:45])[C@@H:40]([CH3:54])[CH2:39]5)[CH:32]=4)[CH:30]=3)=[O:22])[CH:18]=[CH:19][CH:20]=2)[CH2:10][CH2:9]1)=O)(C)C.Cl>O1CCOCC1>[F:55][C:28]1[CH:27]=[CH:26][C:25]([CH2:24][NH:23][C:21]([C:17]2[CH:18]=[CH:19][CH:20]=[C:15]([CH2:14][CH:11]3[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]3)[CH:16]=2)=[O:22])=[CH:30][C:29]=1[C:31]1[CH:36]=[CH:35][CH:34]=[C:33]([CH2:37][N:38]2[CH2:43][CH2:42][N:41]([C:44]([O:46][CH2:47][C:48]3[CH:49]=[CH:50][CH:51]=[CH:52][CH:53]=3)=[O:45])[C@@H:40]([CH3:54])[CH2:39]2)[CH:32]=1参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of phenylmethyl (2S)-4-[(5′-{[({3-[(1-{[(1,1-dimethylethyl)oxy]carbonyl}-4-piperidinyl)methyl]phenyl}carbonyl)amino]methyl}-2′-fluoro-3-biphenylyl)methyl]-2-methyl-1-piperazinecarboxylate (673 mg, 0.90 mmol) in 5 mL of 1,4-dioxane was added 5 mL of 4M HCl in 1,4-dioxane. The mixture was stirred at room temperature for 30 min. After removal of the solvent, the crude was purified by Gilson reverse phase HPLC, eluting with acetonitrile/water/0.1% TFA (10/90 to 70/30, v/v, over 12 min), to give the title compound (390 mg, 67%). LC/MS: m/z, 649 (M+H), 1.69 min.
後処理
- customAfter removal of the solvent
- customthe crude was purified by Gilson reverse phase HPLC
- washeluting with acetonitrile/water/0.1% TFA (10/90 to 70/30, v/v, over 12 min)
出典と根拠
- ORDレコード
- ord-d9043d816aa04eedb11a02d6fa945559
- 出典データセット
- uspto-grants-2011_04
- 特許番号
- US07932247B2
反応ノート
読み込み中…